WashU Medicine-led trial evaluating investigational drug from Eli Lilly and Company aims to stop disease before symptoms arise Researchers at Washington University School of Medicine in St. Louis have ...

The test could help identify one key Alzheimer's biomarker, tau protein, before it shows up in brain. Here's what experts say ...

A study at Lund University reveals that traumatic brain injury alters the small vessels in the brain, resulting in an accumulation of amyloid beta—a hallmark of Alzheimer's disease. The findings ...

An increased risk of dementia among individuals exposed to brain trauma, traumatic brain injury, has been known for almost a century.

Scientists believe they have found a major link between Alzheimer's disease and a dieting hack, which is followed by millions ...

Researchers at Washington University School of Medicine in St. Louis have conducted a longitudinal study on an individual ...

Leqembi (lecanemab) and Kisunla (donanemab) are proven to slow cognitive and functional decline by 27 and 35%, respectively.

A study at Lund University reveals that traumatic brain injury alters the small vessels in the brain, resulting in an accumulation of amyloid beta — a hallmark of Alzheimer’s disease. The findings ...

If you are running a medical research project seeking a cure for cancer or a novel way to employ RNA or an effective way to combat the amyloid plaque buildup that causes Alzheimer's Disease, you will ...

A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau.

Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,” Charles Piller looks how the amyloid hypothesis took over ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test can detect small amounts of the clumping-prone tau protein and its misfolded pathological forms ...